Direkt zum Inhalt
Merck

PLSCR1/IP3R1/Ca

Cell death & disease (2017-05-12)
Hui Li, Jingyan Xu, Yuxin Zhou, Xiao Liu, L E Shen, Y U Zhu, Zhiyu Li, Xiaotang Wang, Qinglong Guo, Hui Hui
ZUSAMMENFASSUNG

Multiple lines of evidence have demonstrated that increased expression of phospholipid scramblase 1 (PLSCR1) is involved in the differentiation of acute myeloid leukemia (AML) cells by several differentiation-inducing agents including ATRA and phorbol 12-myristate 13-acetate. However, none of these agents can achieve nonhomogenous subcellular distribution of PLSCR1. We have demonstrated that wogonoside possesses differentiation and anti-leukemic effects in AML cell lines by promoting PLSCR1 trafficking into nucleus. Here we report that wogonoside promotes the expression of PLSCR1 and enhances its nuclear translocation and binding to the 1, 4, 5-trisphosphate receptor 1 (IP3R1) promoter in AML patient-derived primary cells. Wogonoside activates IP3R1, in turn, promotes release of Ca

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Wogonosid, ≥95% (LC/MS-ELSD)
Sigma-Aldrich
MISSION® esiRNA, targeting human PLSCR1